Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 16/20 | 1.00 |
| ▸ | MAOA | P21397 | 14/20 | 1.00 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.72 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.70 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6168425 | 1.00 | MAOB (1.00) | MAOBMAOASPHK1SCN3ASPHK2 | |
| SCHEMBL6169200 | 0.97 | MAOB (0.94) | MAOBMAOASPHK1SCN3A | |
| SCHEMBL6169206 | 0.97 | MAOB (0.94) | MAOBMAOASPHK1SCN3A | |
| SCHEMBL29288238 | 0.94 | MAOB (1.00) | MAOBMAOASPHK1SCN3A | |
| SCHEMBL29288210 | 0.94 | MAOB (1.00) | MAOBMAOASPHK1SCN3A | |
| SCHEMBL29288213 | 0.94 | MAOB (1.00) | MAOBMAOASPHK1SCN3A | |
| SCHEMBL6169065 | 0.92 | MAOB (0.85) | MAOBMAOASPHK1SCN3ASPHK2 | |
| SCHEMBL6169069 | 0.92 | MAOB (0.85) | MAOBMAOASPHK1SCN3ASPHK2 | |
| SCHEMBL6167500 | 0.88 | MAOB (0.79) | MAOBMAOASPHK1SCN3ASPHK2 | |
| SCHEMBL6167507 | 0.88 | MAOB (0.79) | MAOBMAOASPHK1SCN3ASPHK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005040108-A1 | PROLINAMIDE DERIVATIVES AS SODIUM AND/OR CALCIUM CHANNEL BLOCKERS OR SELECTIVE MAO-B INHIBITORS | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-05-06 | — | — | WO | claimed |
| EP-1524265-A1 | Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors | Newron Pharmaceuticals S.p.A. (IT) | 2005-04-20 | — | — | EP | claimed |
| WO-2005040108-A1 | PROLINAMIDE DERIVATIVES AS SODIUM AND/OR CALCIUM CHANNEL BLOCKERS OR SELECTIVE MAO-B INHIBITORS | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-05-06 | — | — | WO | disclosed |
| EP-1524265-A1 | Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors | Newron Pharmaceuticals S.p.A. (IT) | 2005-04-20 | — | — | EP | disclosed |